Staff
Personnel at the end of the year
Staff turnover in EUR
Turnover Label
The stock: denominated in EURO
Shares outstanding (in millions)
Dividend per share
Undiluted earnings per share
Boss v Mio. EURO nach IAS / IFRS
Turnover
Operating income (EBIT)
Profit before tax (EBT)
Annual net profit/ loss
Balance sheet in millions of Euro IAS / IFRS
Assets
Total current assets
Total fixed assets
Total assets
Liabilities
Total short-term liabilities
Total long-term liabilities
Total provisions
Equity capital
Total liabilities
Management:
Giovanni Di Napoli
Andrea Cherubini
Davide Malavasi
Diana Harbort
Dominika Spilarova
Egle Gedrimaite
Federico Sommariva
Luigi Longo
Nhan Ngo Dingh
Niall Donnelly
Svetlana Sigalova
Board:
Alessandro Chà
Maria Grazia Roncarolo
John O'Dea
Mauro Ajani
Niall Donnelly
Silvana Perretta
Shareholding in %:
Artisan Partners LP 0.84
BlackRock Fund Advisors 0.73
Cosmo Pharmaceuticals NV 8.71
Gerald Herz 7.77
JPMorgan Asset Management (UK) Ltd. 1.77
Mauro Severino Ajani 34.98
The Vanguard Group, Inc. 1.87
UBS Asset Management Switzerland AG 2.87
Zürcher Kantonalbank (Investment Management) 1.21
dievini Hopp BioTech holding GmbH & Co. KG 3.8
Freefloat 35.45
Address: Riverside II, Sir John Rogerson's Quay, 2 Dublin
T: +353-1-8170370
F: +353-1-8230718
I: http://www.cosmopharma.com
E: